News

Weight loss injection: protection for the heart

After DZHK researchers at TUM had already shown that weight-loss injections can reduce the risk of hospitalization or death by more than 40 percent in…

Read more

Alexander Meyer takes over professorship for artificial intelligence in medicine

Artificial intelligence (AI) will shape the healthcare of tomorrow. It is already playing an increasingly important role in many areas today – from…

Read more

Disturbed calcium signals as a cause of atrial fibrillation and cardiac arrhythmia

A joint study by Göttingen University Medical Centre (UMG) and Würzburg University Hospital provides new insights into why heart muscle cells lose…

Read more

How the heart maintains its shape and function – and what can go wrong

A team from the DZHK sites in Heidelberg/Mannheim and Berlin has discovered that a single enzyme in the heart plays a key role in determining whether…

Read more

New Reference Map Reveals How Cells Interact in Heart Failure

When the heart loses its pumping power, it’s not just the heart muscle that changes—entire tissue structures are affected. Numerous cell types respond…

Read more

Cystine metabolism: key to vascular regeneration in ageing and injury

The uptake and oxidative degradation of cystine in the cell nucleus promote the growth and repair of blood vessels via nutrient-dependent histone…

Read more

Lipids as key factors in cardiovascular disease

Lipids are not just energy sources and structural components of cell membranes – they also act as molecules that transmit signals within and between…

Read more

As blood vessels age, so does the heart

New study shows where the crucial changes associated with ageing take place in heart tissue.

Read more

The secret of muscle regeneration: the intact cell nucleus

Muscle stem cells ensure repair of muscles after injury a person's lifetime. This ability relies on the stability of the cells themselves. Scientists…

Read more

A potential drug for treating stiff hearts

Michael Gotthardt (DZHK PI) at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized…

Read more